Top Markets
#1 Akedo Akedo +111.38%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.38%
#4 Black Phoenix Black Phoenix +34.09%
#5 Velvet Velvet +33.20%
#6 Cross Cross +32.71%
#7 OVERTAKE OVERTAKE +18.40%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.83%
#9 QANplatform QANplatform +14.54%
#10 Illuvium Illuvium +12.98%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
BNB Plus Corp. BNB Plus Corp.

BNB Plus Corp.

BNBX
Rank in Stocks #38647
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a... BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Share Price
$0.09
Last synced: 2026-07-28
Market Cap
$876.21K
Change (1 day)
0.00%
Change (1 year)
-97.79%
Country
US
Trade BNB Plus Corp. (BNBX)

Category

Healthcare
Stock price history for BNB Plus Corp. (BNBX)
Highest end of day price: $0.20 on 2026-07-01

Lowest end of day price: $3.96M on 2006-06-01
Stock price history of BNB Plus Corp. from 2006 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -32.54%
2025 -98.22%
2024 -98.74%
2023 -46.39%
2022 -71.32%
2021 -19.55%
2020 50.29%
2019 -86.89%
2018 -63.54%
2017 2.62%
2016 -37.30%
2015 17.11%
2014 -59.86%
2013 -10.26%
2012 95.00%
2011 22.22%
2010 -26.83%
2009 74.47%
2008 -60.62%
2007 24.71%
2006 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.94 30.14%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.71 29.78%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE